All Blogs / Health / Mental Health / Alzheimer's / New


Taking proton pump inhibitors not linked to higher dementia risk

Scientists have concluded that developing dementia or Alzheimer's disease (the most common form of dementia) did not appear to be linked to taking proton pump inhibitors (PPIs).

Imaging technique shows progress Alzheimer's disease

Using ‘Raman’ optical technology, scientists can now produce images of brain tissue that is affected by Alzheimer’s disease. The images include the surrounding areas, already showing changes.

How to Use Bright Light to Improve Mood and Behavior in Alzheimer's Patients

One of the most important things I learned as an Alzheimer's caregiver was how to use bright light to change my mother's mood and behavior. By Bob DeMarco Alzheimer's Reading Room My mother, Dotty, had a tendency to get in a bad mood around 4:30 PM each day. Show More Summary

Researchers Discover Where the Earliest Signs of Alzheimer's Occur in the Brain

Researchers at Lund University in Sweden have for the first time shown where in the brain the earliest signs of Alzheimer's occur. By Alzheimer's Reading Room The discovery could potentially become significant to future Alzheimer's research...Show More Summary

My Father with Alzheimer's Stares at Us and it Feels Creepy

Think of your father as being swept away by currents of memories that cause him to appear as if he is staring at you, but he may instead be reliving powerful memories. By Rita Jablonski Alzheimer's Reading Room Our friends at Alzheimer's...Show More Summary

How bacteria in the gut influence neurodegenerative disorders

Humans have roughly as many bacterial cells in their bodies as human cells, and most of those bacteria live in the gut. New research released today reveals links between the gut microbiome -- the population of microorganisms living in...Show More Summary

U.S. health care system unprepared to move future Alzheimer's treatment into rapid clinical use

Advanced clinical trials are underway for at least 10 investigational therapies that have shown promise in slowing or blocking development of Alzheimer's disease, creating hope that a preventive strategy may be in reach. But a new study warns that the U.S. Show More Summary

Parkinson's disease: A looming pandemic

The number of people with Parkinson's disease will soon grow to pandemic proportions, research concludes. In a new article, researchers argue that the medical community must be mobilized to respond to this impending public health threat.

New player in Alzheimer's disease pathogenesis identified

Scientists have shown that a protein called membralin is critical for keeping Alzheimer's disease pathology in check. The study shows that membralin regulates the cell's machinery for producing beta-amyloid (or amyloid beta), the protein that causes neurons to die in Alzheimer's disease.

Bill Gates Invests $100 Million into Alzheimer's Research

Bill Gates is investing $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments for Alzheimer's disease. Gates will also invest an additional $50 million in start-up...Show More Summary

Biomarker may predict early Alzheimer's disease

Researchers have identified a peptide that could lead to the early detection of Alzheimer's disease (AD). The discovery may also provide a means of homing drugs to diseased areas of the brain to treat AD, Parkinson's disease, as well as glioblastoma, brain injuries and stroke.

Dementia treatment research: Exit through the lymphatic system

Scientists have disproved a decades-old orthodoxy: cerebrospinal fluid does not leave the cranial cavity via blood vessels, but instead through the lymphatic system. This finding has far-reaching implications in new treatments for dementia.

Neurodegenerative diseases: Transforming fibrils into crystals

Researchers have discovered a new type of transition in protein folding: amyloid crystals formed from amyloid fibrils by a decrease in energy. The crystals are even more stable than the fibrils, which are responsible for a number of serious neurodegenerative diseases in humans.

Potential treatment to stop glaucoma in its tracks

Vision scientists have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma, the world's second-leading cause of blindness.

How SORLA protects against Alzheimer's disease

Researchers have identified a new protective function for a brain protein genetically linked to Alzheimer's. The findings could inform novel treatment strategies to combat neurodegenerative diseases.

Saving neurons may offer new approach for treating Alzheimer's disease

Treatment with a neuroprotective compound that saves brain cells from dying also prevents the development of depression-like behavior and the later onset of memory and learning problems in a rat model of Alzheimer's disease, according to new research. Show More Summary

Afraid of Making the Wrong Caregiver Moves?

Behind every good caregiving intention is usually a fair amount of love and caring. By Paula Spencer Scott Alzheimer's Reading Room Are you sometimes nagged by the question, Am I getting this right? What is the Difference Between Alzheimer’s...Show More Summary

Nanosensors demystify brain chemistry

Nanosensors are incredible information-gathering tools for myriad applications, including molecular targets such as the brain. Neurotransmitter molecules govern brain function through chemistry found deep within the brain, so researchers are developing nanosensors to gain a better understanding of exactly how this all plays out.

Blood-clotting protein prevents repair in the brain

Scientists have uncovered a promising new therapeutic strategy to repair myelin in the brain. Surprisingly, it's associated with a protein in the blood.

Alzheimer's World -- Two Circles Trying to Reconnect

It takes lots of thought, hard work, and the development of a new mental construct of communication and behavior to understand Alzheimer's disease. By Bob DeMarco Alzheimer's Reading Room It takes lots of thought, hard work, and the development of a new mental construct of communication and behavior to understand Alzheimer's disease. Show More Summary

Copyright © 2015 Regator, LLC